A Phase II Study of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma
Phase of Trial: Phase II
Latest Information Update: 03 Aug 2017
At a glance
- Drugs Bevacizumab (Primary) ; Carboplatin (Primary) ; Paclitaxel (Primary)
- Indications Endometrial cancer
- Focus Therapeutic Use
- 28 Jul 2017 Status changed from active, no longer recruiting to completed.
- 03 May 2012 Planned End Date changed from 1 Aug 2011 to 1 Aug 2012 as reported by ClinicalTrials.gov.
- 09 Sep 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.